| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.06 |